Vitreomacular traction syndrome: New non-surgical treatments
Author(s) -
Paula Maqueda-González,
Pablo de Marcelo-Benito
Publication year - 2018
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 2604-1731
DOI - 10.24875/rmoe.m18000009
Subject(s) - traction (geology) , medicine , dermatology , ophthalmology , engineering , mechanical engineering
Vitreomacular traction syndrome is described as a maculopathy in which incomplete vitreous detachment associated with macular traction and visual acuity decrease occurs. clinical case: We present the case of a 54-year-old female with bilateral vitreomacular traction syndrome not coincident in time. In the right eye, it resolved spontaneously after 12 months of follow-up. The left eye was treated by pharmacological vitreolysis with ocriplasmin (JETREA®, Alcon Laboratories, Fort Worth, TX, USA), achieving functional and anatomical recovery in 3 months. Discussion: Enzymatic vitreolysis achieves a fundamental early treatment to obtain good results that allow maximum preservation of visual function and retinal anatomy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom